BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6195708)

  • 1. Pitfalls in the methodology for detection of immune complexes.
    Heimer R; Per S
    Surv Immunol Res; 1982; 1(1):109-16. PubMed ID: 6195708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methods of determining circulating immune complexes].
    Baleva M
    Vutr Boles; 1983; 22(6):1-5. PubMed ID: 6369791
    [No Abstract]   [Full Text] [Related]  

  • 3. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies.
    Golan MD; Burger R; Loos M
    J Immunol; 1982 Aug; 129(2):445-7. PubMed ID: 6177765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems in the detection of complement-fixing immune complexes.
    Rødahl E
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of circulating immune complexes by enzyme immunoassay. A basic study of C1q enzyme immunoassay and anti-C3 enzyme immunoassay using microplates].
    Yokoyama K
    Arerugi; 1984 Feb; 33(2):117-26. PubMed ID: 6380453
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complex assays and their limitations.
    Kilpatrick DC; Weston J
    Med Lab Sci; 1985 Apr; 42(2):178-85. PubMed ID: 2933572
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal rheumatoid factor-IgG immune complexes. Poor fixation of opsonic C4 and C3 despite efficient complement activation.
    Ng YC; Peters DK; Walport MJ
    Arthritis Rheum; 1988 Jan; 31(1):99-107. PubMed ID: 3345233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating immune complexes in a population of subjects seropositive for rheumatoid factor].
    Aureli G; Battista V; Bianchi L; Bolzonetti A; Cipriani A; Carnevali GF; Caschera F; Caputo B; Danieli G; Corvetta A
    Boll Ist Sieroter Milan; 1982; 61(5):367-74. PubMed ID: 6985415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for detection of low molecular weight DNA--anti-DNA complexes in systemic lupus erythematosus.
    Agnello V; Mitamura T
    Arthritis Rheum; 1982 Jul; 25(7):788-92. PubMed ID: 7049182
    [No Abstract]   [Full Text] [Related]  

  • 15. Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum.
    Witkin SS; Shahani SK; Gupta S; Good RA; Day NK
    Clin Exp Immunol; 1980 Sep; 41(3):441-52. PubMed ID: 6160008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against an immune complex pathogenesis of primary biliary cirrhosis.
    Goldberg MJ; Kaplan MM; Mitamura T; Anderson CL; Matloff DS; Pinn VW; Agnello V
    Gastroenterology; 1982 Sep; 83(3):677-83. PubMed ID: 6212278
    [No Abstract]   [Full Text] [Related]  

  • 17. The absence of circulating immune complexes in patients with ankylosing spondylitis.
    Maksymowych W; Dasgupta MK; Rothwell RS; Dossetor JB; Russell AS
    Rheumatol Int; 1981; 1(3):107-9. PubMed ID: 6981182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The [125I]C1q binding assay for the detection of soluble immune complexes.
    Zubler RH; Carpentier N; Lambert PH
    Methods Enzymol; 1981; 74 Pt C():530-7. PubMed ID: 6976503
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune complexes in diabetes mellitus: studies of complement utilisation and tissue deposition.
    Charlesworth JA; Campbell LV; Catanzaro R; Pussell BA; Pasterfield GV; Peake P
    J Clin Lab Immunol; 1982 Sep; 8(3):163-8. PubMed ID: 6752415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.